Optikem International Inc.

Warning LetterOpen

United StatesFEI 1720129Issued Jun 20, 2024Division of Pharmaceutical Quality Operations IV

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 1720129.

Violations0

Issue DateJun 20, 2024

Product TypeDrugs

StatusOpen

Letter Details

Firm: Optikem International Inc.
Location: United States
FEI Number: 1720129
Country: United States
Issue Date: June 20, 2024
Issuing Office: Division of Pharmaceutical Quality Operations IV
Product Type: Drugs
Status: Open

Summary

Based on limited metadata, Optikem International Inc., a pharmaceutical company, received an FDA Warning Letter on June 20, 2024, regarding drug products. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The warning relates to FDA drug regulation and enforcement, though the specific issuing office and violation count are not documented in the metadata provided.

Optikem International Inc. FDA Warning Letter, June 20, 2024